Suppr超能文献

用于复发性胶质母细胞瘤治疗的外照射再照射、联合放化疗及粒子治疗。

External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.

作者信息

Taunk Neil K, Moraes Fabio Y, Escorcia Freddy E, Mendez Lucas Castro, Beal Kathryn, Marta Gustavo N

机构信息

a Department of Radiation Oncology , Memorial Sloan Kettering Cancer Center , New York , New York , USA.

b Department of Radiation Oncology , Hospital Sírio-Libanês , São Paulo , Brazil.

出版信息

Expert Rev Anticancer Ther. 2016;16(3):347-58. doi: 10.1586/14737140.2016.1143364. Epub 2016 Feb 9.

Abstract

Glioblastoma is a common aggressive primary malignant brain tumor, and is nearly universal in progression and mortality after initial treatment. Re-irradiation presents a promising treatment option for progressive disease, both palliating symptoms and potentially extending survival. Highly conformal radiation techniques such as stereotactic radiosurgery and hypofractionated radiosurgery are effective short courses of treatment that allow delivery of high doses of therapeutic radiation with steep dose gradients to protect normal tissue. Patients with higher performance status, younger age, and longer interval between primary treatment and progression represent the best candidates for re-irradiation. Multiple studies are also underway involving combinations of radiation and systemic therapy to bend the survival curve and improve the therapeutic index. In the multimodal treatment of recurrent high-grade glioma, the use of surgery, radiation, and systemic therapy should be highly individualized. Here we comprehensively review radiation therapy and techniques, along with discussion of combination treatment and novel strategies.

摘要

胶质母细胞瘤是一种常见的侵袭性原发性恶性脑肿瘤,初次治疗后几乎都会进展并导致死亡。再程放疗是治疗进展性疾病的一种有前景的选择,既能缓解症状,又有可能延长生存期。立体定向放射外科和低分割放射外科等高适形放疗技术是有效的短疗程治疗方法,可实现高剂量治疗性辐射的递送,并具有陡峭的剂量梯度以保护正常组织。身体状况较好、年龄较轻以及初次治疗与病情进展之间间隔较长的患者是再程放疗的最佳候选者。多项研究也在进行中,涉及放疗与全身治疗的联合应用,以改变生存曲线并提高治疗指数。在复发性高级别胶质瘤的多模式治疗中,手术、放疗和全身治疗的使用应高度个体化。在此,我们全面综述放疗及技术,并讨论联合治疗和新策略。

相似文献

1
External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.
Expert Rev Anticancer Ther. 2016;16(3):347-58. doi: 10.1586/14737140.2016.1143364. Epub 2016 Feb 9.
3
Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.
World Neurosurg. 2013 Dec;80(6):872-8. doi: 10.1016/j.wneu.2013.02.030. Epub 2013 Feb 9.
5
Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma.
Neurol Med Chir (Tokyo). 2012;52(8):548-52. doi: 10.2176/nmc.52.548.
6
Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
Acta Neurol Scand. 2017 Sep;136(3):239-245. doi: 10.1111/ane.12719. Epub 2016 Dec 26.
7
Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
Technol Cancer Res Treat. 2011 Jun;10(3):253-8. doi: 10.7785/tcrt.2012.500200.
8
Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Acta Oncol. 2013 Jan;52(1):147-52. doi: 10.3109/0284186X.2012.692882. Epub 2012 Jun 11.
9
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):636-42. doi: 10.1016/j.ijrobp.2012.05.031. Epub 2012 Jul 3.
10
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
J Neurooncol. 2024 Apr;167(2):295-303. doi: 10.1007/s11060-024-04607-4. Epub 2024 Feb 22.

引用本文的文献

1
Harnessing Arsenic Derivatives and Natural Agents for Enhanced Glioblastoma Therapy.
Cells. 2024 Dec 23;13(24):2138. doi: 10.3390/cells13242138.
3
Bevacizumab combined with re-irradiation in recurrent glioblastoma.
Front Oncol. 2022 Aug 4;12:961014. doi: 10.3389/fonc.2022.961014. eCollection 2022.
4
Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Invest New Drugs. 2022 Apr;40(2):255-264. doi: 10.1007/s10637-021-01201-7. Epub 2021 Nov 24.
5
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma.
Strahlenther Onkol. 2022 May;198(5):427-435. doi: 10.1007/s00066-021-01844-8. Epub 2021 Sep 14.
7
Low Fraction Size Re-irradiation for Large Volume Recurrence of Glial Tumours.
Pathol Oncol Res. 2020 Oct;26(4):2651-2658. doi: 10.1007/s12253-020-00868-2. Epub 2020 Jul 9.
9
How We Treat Recurrent Glioblastoma Today and Current Evidence.
Curr Oncol Rep. 2019 Oct 12;21(10):94. doi: 10.1007/s11912-019-0834-y.

本文引用的文献

2
Neurocognitive challenges in brain tumor survivors: is there anything we can do?
J Clin Oncol. 2015 May 20;33(15):1633-6. doi: 10.1200/JCO.2014.60.2805. Epub 2015 Apr 20.
3
Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
Neurol Sci. 2015 Aug;36(8):1431-40. doi: 10.1007/s10072-015-2172-7. Epub 2015 Mar 25.
4
A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.
Clin Cancer Res. 2014 Dec 15;20(24):6304-13. doi: 10.1158/1078-0432.CCR-14-0951-T. Epub 2014 Oct 22.
5
Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas.
Ann Transl Med. 2014 May;2(5):44. doi: 10.3978/j.issn.2305-5839.2014.05.06.
6
Interaction of radiation therapy with molecular targeted agents.
J Clin Oncol. 2014 Sep 10;32(26):2886-93. doi: 10.1200/JCO.2014.55.1366. Epub 2014 Aug 11.
7
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Clin Cancer Res. 2014 Oct 1;20(19):5023-31. doi: 10.1158/1078-0432.CCR-14-0822. Epub 2014 Aug 8.
8
Salvage radiosurgery for selected patients with recurrent malignant gliomas.
Biomed Res Int. 2014;2014:657953. doi: 10.1155/2014/657953. Epub 2014 May 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验